B1 Non-refereed article in a scientific journal

[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.



Authors: Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM

Publisher: Springer

Publication year: 2020

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Journal name in source: European journal of nuclear medicine and molecular imaging

Journal acronym: Eur J Nucl Med Mol Imaging

Volume: 47

Issue: 3

First page : 579

Last page: 591

Number of pages: 13

ISSN: 1619-7070

eISSN: 1619-7089

DOI: https://doi.org/10.1007/s00259-019-04614-y


Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [18F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of [18F]Fluciclovine PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.



Last updated on 2024-26-11 at 23:52